Office of the Director, National Institutes of Health; Notice of Meeting, 31627 [2012-12860]
Download as PDF
Federal Register / Vol. 77, No. 103 / Tuesday, May 29, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
srobinson on DSK4SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as amended
because the premature disclosure of
grant applications and the discussions
would likely to significantly frustrate
implementation of recommendations.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: June 14–15, 2012.
Open: June 14, 2012, 9:00 a.m. to 5:00 p.m.
Agenda: NIH Director’s Report, ACD
Working Group report, NIH Updates and
other business of the committee.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892.
Closed: June 15, 2012, 8:00 a.m. to 9:00
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892.
Open: June 15, 2012, 9:00 a.m. to 12:00
p.m.
Agenda: ACD Working Group reports, NIH
updates, and other business of the
committee.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
VerDate Mar<15>2010
16:12 May 25, 2012
Jkt 226001
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: May 21, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–12860 Filed 5–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel COBRE (P20).
Date: June 19–20, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lee Warren Slice, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 1
Democracy Plaza, 6701 Democracy
Boulevard, Room 1068, Bethesda, MD 20892,
301–435–0807, slicelw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, CellBiology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
31627
Dated: May 21, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–12859 Filed 5–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors for Clinical
Sciences and Epidemiology National
Cancer Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology; National Cancer Institute.
Date: July 10, 2012.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, 6116 Executive
Boulevard, Room 2201, Bethesda, MD 20892,
(301) 496–7628, wojcikb@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/cse/cse.
htm, where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\29MYN1.SGM
29MYN1
Agencies
[Federal Register Volume 77, Number 103 (Tuesday, May 29, 2012)]
[Notices]
[Page 31627]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12860]
[[Page 31627]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Advisory Committee to the Director, National Institutes of Health.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as
amended because the premature disclosure of grant applications and the
discussions would likely to significantly frustrate implementation of
recommendations.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: June 14-15, 2012.
Open: June 14, 2012, 9:00 a.m. to 5:00 p.m.
Agenda: NIH Director's Report, ACD Working Group report, NIH
Updates and other business of the committee.
Place: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Closed: June 15, 2012, 8:00 a.m. to 9:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Open: June 15, 2012, 9:00 a.m. to 12:00 p.m.
Agenda: ACD Working Group reports, NIH updates, and other
business of the committee.
Place: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 21, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-12860 Filed 5-25-12; 8:45 am]
BILLING CODE 4140-01-P